Position in JNJ
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$2,873,416
+$41,824 QoQ
Shares Held
11,314
-2.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#2,029
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TRILLIUM ASSET MANAGEMENT, LLC holds $65,640,925 across 8 Drug Manufacturers - General names. JNJ ranks #4 (4.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
208,971 | $39,625,081 | |
| 2 | MRK |
Merck & Co., Inc.
|
87,017 | $11,181,684 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
75,118 | $9,490,408 | |
| 4 | JNJ |
Johnson & Johnson
This page
|
11,314 | $2,873,416 | |
| 5 | NVO |
Novo Nordisk A S
|
19,689 | $943,890 | |
| 6 | ABBV |
AbbVie Inc.
|
2,843 | $715,412 | |
| 7 | LLY |
ELI LILLY & Co
|
359 | $430,595 | |
| 8 | PFE |
Pfizer Inc
|
15,799 | $380,439 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,873,416 | 11,314 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $2,831,592 | 11,584 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $2,543,001 | 12,288 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $2,293,830 | 12,371 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,908,305 | 12,493 | Shares | Defined | 2025-08-06 | |
| 2025-03-31 | $2,070,346 | 12,484 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,836,240 | 12,697 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $2,142,919 | 13,223 | Shares | Defined | 2024-11-07 | |
| 2024-06-30 | $1,939,981 | 13,273 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $2,215,134 | 14,003 | Shares | Defined | 2024-05-09 | |
| 2023-12-31 | $2,203,450 | 14,058 | Shares | Defined | 2024-02-08 | |
| 2023-09-30 | $2,338,119 | 15,012 | Shares | Defined | 2023-11-08 | |
| 2023-06-30 | $2,570,194 | 15,528 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $2,520,145 | 16,259 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $2,842,475 | 16,091 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $2,686,291 | 16,444 | Shares | Defined | 2022-11-09 | |
| 2022-06-30 | $2,847,437 | 16,041 | Shares | Defined | 2022-08-08 | |
| 2022-03-31 | $8,689,409 | 49,029 | Shares | Defined | 2022-05-04 | |
| 2021-12-31 | $3,358,104 | 19,630 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $2,890,204 | 17,896 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $4,078,138 | 24,755 | Shares | Defined | 2021-11-12 | |
| 2021-03-31 | $4,335,717 | 26,381 | Shares | Other | 2021-05-10 | |
| 2020-12-31 | $3,731,637 | 23,711 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $3,536,792 | 23,756 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $3,519,406 | 25,026 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $3,525,560 | 26,886 | Shares | Other | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||